Elevated plasma concentration of reduced homocysteine in patients with human immunodeficiency virus infection

American Journal of Clinical Nutrition

Volumn 63, Issue 2, 1996, Pages 242-248

  Müller, Fredrik ^a   Svardal, Asbjørn M ^b   Aukrust, Pål ^b   Berge, Rolf K ^b   Ueland, Per M ^b   Frøland, Stig S ^b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b NONE

Author keywords

cysteine; Homocysteine; human immunodeficiency virus; methionine; oxidative stress

Indexed keywords

CYSTEINE; HOMOCYSTEINE; METHIONINE;

AMINO ACID METABOLISM; ARTICLE; CLINICAL ARTICLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; LYMPHOCYTE ACTIVATION; OXIDATIVE STRESS; PROGNOSIS; PROTEIN BLOOD LEVEL; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0030070785     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/63.2.242     Document Type: Article

References (52)

1. Sies H. Oxidative stress: from basic research to clinical application. Am J Med 1991;91:31S-8S.
2. Staal FJT, Ela SW, Roederer M, Anderson MT, Herzenberg LA. Glutathione deficiency and human immunodeficiency virus infection. Lancet 1992;339:909-12.
3. Baruchel S, Wainberg MA. The role of oxidative stress in disease progression in individuals infected by the human immunodeficiency virus. J Leukocyte Biol 1992;52:111-4.
4. Droge W. Cysteine and glutathione deficiency in AIDS patients - a rationale for the treatment with N-acetyl-cysteine. Pharmacology 1993;46:61-5.
5. Müller F. Reactive oxygen intermediates and human immunodeficiency virus (HIV) infection. Free Radie Biol Med 1992;13:651-7.
6. Hamilos DL, Wedner HJ. The role of glutathione in lymphocyte activation. I. Comparison of inhibitory effects of buthionine sulfoximine and 2-cyclohexene-1-one by nuclear size formation. J Immunol 1985;135:2740-7.
7. Yamauchi A, Bloom ET. Requirement of thiol compounds as reducing agents for IL-2 mediated induction of LAK activity and proliferation of human NK cells. J Immunol 1993,151:5535-44.
8. Droge W, Pottmeyer-Greber C, Schmidt H, Nick S. Glutathione augments the activation of cytotoxic T lymphocytes in vivo. Immunobiology 1986;171:151-6.
9. Buttke TM, Sandstrom PA. Oxidative stress as a mediator of apoptosis. Immunol Today 1994;15:7-10.
10. Sandstrom PA, Mannie MD, Buttke TM. Inhibition of activationinduced death in T cell hybridomas by thiol antioxidants - oxidative stress as a mediator of apoptosis. J Leukocyte Biol 1994;55: 221-6.
11. Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J 1991;10:2247-58.
12. Staal FJT. Roederer M, Herzenberg LA, Herzenberg LA. Intracellular thiols regulate activation of nuclear factor kappaB and transcription of human immunodeficiency virus. Proc Natl Acad Sci USA 1990;87: 9943-7.
13. Meister A. Glutathione ascorbic acid antioxidant system in animals. J Biol Chem 1994;269:9397-400.
14. Buhl R, Jaffe HA, Holroyd KJ, et al. Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet 1989; 2:1294-8
15. Staal FJT, Roederer M, Israelski DM, et al. Intracellular glutathione levels in T-cell subsets decrease in HIV-infected individuals. AIDS Res Hum Retroviruses 1992;8:305-11
16. Roederer M, Staal FJT, Osada H, Herzenberg LA. CD4 and CDS T-cells with high intracellular glutathione levels are selectively lost as the HIV infection progresses. Int Immunol 1991;3:933-7
17. Eck HP, Gmünder H, Hartmann M, Petzoldt D, Daniel V, Droge W. Low concentrations of acid-soluble thiol (cysteine) in the blood plasma of HIV-1-infected patients. Biol Chem Hoppe Seyler 1989; 370:101-8.
18. Jacobsen DW, Green R, Herbert V, Longworth DL. Rehm S. Decreased serum glutathione with normal cysteine and homocysteine levels in patients with AIDS. Clin Res 1990;38:556A(abstr).
19. Dequay B, Malinverni R, Lauterburg BH. Glutathione depletion in HIV-infected patients - role of cysteine deficiency and effect of oral N-acetylcysteine. AIDS 1992;6:815-9.
20. Hortin GL, Landt M, Powderly WG. Changes in plasma amino acid concentrations in response to HW-1. Clin Chem 1994;40:785-9.
21. Aukrust P, Svardal AM, Müller F, Lunden B, Ueland PM, Frøland SS. Increased levels of oxidized glutathione in CD4+ lymphocytes associated with disturbed intracellular redox balance in human immunodeficiency virus type 1 infection. Blood 1995;86:258-67.
22. Preibisch G, Kuffner C, Elstner EF. Biochemical model reactions on the prooxidative activity of homocysteine. Z Naturforsch [C] 1993; 48c:58-62.
23. Munday R. Toxicity of thiols and disulphides: involvement of freeradical species. Free Radic Biol Med 1989;7:659-73.
24. Kang S-S, Wong PWK, Malinow MR. Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Annu Rev Nutr 1992;12:279-98.
25. Ueland PM, Refsum H, Stabler SP, Malinow MR. Andersson A, Allen RH. Total homocysteine in plasma or serum. Methods and clinical applications. Clin Chem 1993;39:1764-79.
26. Wall RT, Harlan JM, Harker LA, Striker GE. Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury. Thromb Res 1980;18:113-21.
27. Starkebaum G, Harlan JM. Endothelial cell injury due to coppercatalyzed hydrogen peroxide generation from homocysteine. J Clin Invest 1986;77:1370-6.
28. Mansoor MA, Bergmark C, Svardal AM, Lønning PE, Ueland PM. Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Arterioscler Thromb Vasc Biol 1995;15:232-40.
29. Meister A, Anderson ME. Glutathione. Annu Rev Biochem 1983:52: 711-60.
30. Ueland PM, Refsum H. Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and therapy. J Lab Clin Med 1989;114:473-501.
31. Centers for Disease Control and Prevention. 1993 revised classification for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992;41:1-19.
32. Mansoor MA, Svardal AM, Ueland PM. Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma. Anal Biochem 1992;200:218-29.
33. Krishnamurti CR, Heindze AM, Galzy G. Application of reverse-phase high-performance liquid chromatography using precolumn derivatization with o-phthaldialdehyde for the quantitative analysis of amino acids in adults and fetal sheep plasma. J Chromatogr 1984;315:321-31.
34. Brinchmann JE, Vartdal F, Gaudernack G, et al. Direct immunomagnetic quantification of lymphocyte subsets in blood. Clin Exp Immunol 1988;71:182-6.
35. Uchiyama T, Broder S, Waldmann TA. A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac(+) cells. J Immunol 1981;126:1393-7.
36. Aukrust P, Liabakk NB, Müller F, Lien E, Espevik T, Frøland SS. Serum levels of tumor necrosis factor-α (TNF-α) and soluble TNF receptors in human immunodeficiency virus type 1 infection - correlations to clinical, immunologic, and virologic parameters. J Infect Dis 1994;169:420-4.
37. Mansoor MA, Ueland PM, Aarsland A, Svardal AM. Redox status and protein binding of plasma homocysteine and other aminothiok in patients with homocystinuria Metabolism 1993;42:1481-5.
38. Mansoor MA, Ueland PM, Svardal AM. Redox status and protein binding of plasma homocysteine and other ammothiols in patients with hyperhomocystememia due to cobalamin deficiency. Am J Clin Nutr 1994;59:631-5.
39. Mansoor MA, Guttormsen AB, Fiskerstrand T, Refsum H, Ueland PM, Svardal AM. Redox status and protein binding of plasma aminothiols during the transient hyperhomocysteinemia that follows homocysteine administration. Clin Chem 1993;39:980-5.
40. Mansoor MA, Svardal AM, Schneede J, Ueland PM. Dynamic relation between reduced, oxidized, and protein-bound homocysteine and other thiol components in plasma during methionme loading in healthy men. Clin Chem 1992;38:136-21.
41. Graham NM, Sorensen D, Odaka N, et al. Relationship of serum copper and zinc levels to HIV-1 seropositivity and progression to AIDS. J Acquir Immune Defic Syndr 1991;4:976-80.
42. Beach RS, Mantero-Atienza E, Shor-Posner G, et al. Specific nutrient abnormalities in asymptomatic HIV-1 infection. AIDS 1992;6:701-8.
43. Schreck R, Meier B, Mannel DN, Droge W, Baeuerle PA. Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells. J Exp Med 1992;175:1181-94.
44. Ubbink JB, Vermaak WJH, van der Merwe A, Becker PJ. The effect of blood sample aging and food consumption on plasma total homocysteine levels. Clin Chim Acta 1992;207:119-28.
45. Andersson A, Brattstrom L, Israelsson B, Isaksson A, Hamfelt A, Hultberg B. Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status. Eur J Clin Invest 1992;22:79-87.
46. Bergmark C, Mansoor MA, Swedenborg J, de Faire U, Svardal AM, Ueland PM. Hyperhomocysteinemia in patients operated for lower extremity ischaemia below the age of 50. Effect of smoking and extent of disease. Eur J Vasc Surg 1993;7:391-6.
47. Rule SAJ, Hooker M, Costello C, Luck W, Hoffbrand AV. Serum vitamin B-12 and transcobalamin levels in early HIV disease. Am J Hematol 1994;47:167-71.
48. Beach RS, Morgan R, Wilkie F, et al. Plasma vitamin B12 level as a potential cofactor in studies of human immunodeficiency virus type 1-related cognitive changes. Arch Neurol 1992;49:501-6.
49. Deneke SM, Fanburg BL. Regulation of cellular glutathione. Am J Physiol 1989;257:L163-73.
50. Droge W, Eck HP, Näher H, Pekar U, Daniel V. Abnormal amino acid concentrations in the blood of patients with acquired immunodeficiency syndrome (AIDS) may contribute to the immunological defect. Biol Chem Hoppe Seyler 1988;369:143-8.
51. Svardal AM, Mansoor MA. Ueland PM. Determination of reduced, oxidized, and protein-bound glutathione in human plasma with precolumn derivatization with monobromobimane and liquid chromatography. Anal Biochem 1990;184:338-46.
52. Roederer M, Staal FJT, Ela SW, Herzenberg LA, Herzenberg LA. N-acetylcysteine - potential for AIDS therapy. Pharmacology 1993; 46:121-9.